[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336094-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336094-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","enzyme-labeled-liquid-based-cytology-ellbc-a-new-noninvasive-diagnostic-method-for-bladder-cancers","Enzyme-labeled liquid-based cytology (ELLBC): a new noninvasive diagnostic method for bladder cancers","","Enzyme-labeled liquid-based cytology (ELLBC) applies enzyme histochemical staining with acid phosphatase as a biomarker to evaluate its diagnostic value for bladder cancer. A study of 50 patients with suspected bladder cancer assessed ELLBC against conventional cytology and histopathology as the gold standard. Results showed ELLBC achieved higher sensitivity and specificity than conventional cytology, while combined testing improved sensitivity with different accuracy. ELLBC also demonstrated strong clinical staging performance, supporting its role in early noninvasive screening.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/enzyme-labeled-liquid-based-cytology-ellbc-a-new-noninvasive-diagnostic-method-for-bladder-cancers/336094/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/enzyme-labeled-liquid-based-cytology-ellbc-a-new-noninvasive-diagnostic-method-for-bladder-cancers/336094.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is ELLBC and what marker does it use?","Question",{"text":63,"@type":64},"ELLBC is an enzyme histochemical staining approach based on liquid-based cytology. It uses acid phosphatase as the marker to detect bladder cancer cells with abnormal elevation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was diagnostic performance of ELLBC evaluated?",{"text":68,"@type":64},"Diagnostic efficacy was calculated by comparing ELLBC and conventional cytology with histopathology, which served as the gold standard.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings about ELLBC versus conventional cytology?",{"text":72,"@type":64},"ELLBC showed higher sensitivity and specificity than conventional cytology, with statistical significance reported (p \u003C 0.05). Combining ELLBC with conventional cytology increased sensitivity, though diagnostic accuracy decreased.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336094,1790176863,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":4},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Journal of Cancer Research and Clinical Oncology (2024) 150:169  \n[https://doi.org/10.1007/s00432-024-05613-9](https://doi.org/10.1007/s00432-024-05613-9)  \nEnzyme‑labeled liquid‑based cytology (ELLBC): a new noninvasive diagnostic method for bladder cancers  \nChao Jiang1 · Xiang Li1 · Ruilong Chen1 · Yongliu Yang2 · Yi Wang1,3  \nReceived: 1 November 2023 / Accepted: 7 January 2024 / Published online: 28 March 2024 © Springer-Verlag GmbH Germany, part of Springer Nature 2024  \nAbstract  \nBackground Based on liquid-based cytology, we performed an enzyme histochemical staining using acid phosphatase as a marker and termed it ELLBC. The aim of this study was to investigate the value ofELLBC in the diagnosis of bladder cancer. Methods Fifty patients who were initially diagnosed with suspected bladder cancers (hematuria or bladder irritation symptoms, urinary ultrasound suggestive of bladder mass) at the Second Affiliated Hospital of Anhui Medical University (Anhui, China) from January 2022 to December 2022 were selected as the study subjects, all of whom underwent ELLBC, CC, and histopathology Histopathology was used as the gold standard to calculate the diagnostic efficacy ofELLBC, CC and ELLBC combined with CC in bladder cancer.  \nResults Histopathological examination revealed 35 positive cases in 50 patients, including 15 cases of high-grade uroepithelial carcinoma (HGUC) and 20 cases of low-grade uroepithelial carcinoma (LGUC.) The sensitivity ofELLBC was 82.86%, the specificity was 93.33%, the positive predictive value (PPV) was 96.67%, the negative predictive value (NPV) was 70.00%, and the accuracy was 86.00%; CC had a sensitivity of 37.14%, specificity of 80.00%, PPV of 81.25%, NPV of 35.29%, and accuracy of 50%; ELLBC combined with CC had a sensitivity of 88.57%, specificity of 73.33%, PPV of 88.57%, NPV of 73.33%, and accuracy of 84.00%. The sensitivity and specificity of ELLBC were higher than that of CC, and the difference was statistically significant (p \u003C 0.05), ELLBC combined with CC achieved higher sensitivity, but the diagnostic accuracy decreased. For clinical staging, the diagnostic accuracy was 86.36% for ELLBC and 40.91% for CC in patients in Stage I, and 90.91% for ELLBC and 36.36% for CC in patients in Stage II.  \nConclusion ELLBC has high clinical application value for the diagnosis of bladder cancer and can provide new options and methods for the early screening of bladder cancer.  \nKeywords Liquid-based cytology · Enzyme histochemical staining · Noninvasive diagnostic · Bladder cancer  \nAbbreviations  \nLBC Liquid-based cytology  \nCC Conventional cytology  \nUC Urothelial cancer  \nHGUC High-grade urothelial cancer  \nLGUC Low-grade urothelial cancer  \n* Yi Wang [wangyi2035@ahmu.edu.cn](wangyi2035@ahmu.edu.cn)  \n1 Department of Urology, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Hefei 230601, China  \n2 Department of Pathology, Hefei Cancer Hospital, Chinese Academy of Sciences, No. 68 Yangqiao Road, Hefei 230088, China  \n3 Anhui Provincial Institute of Translational Medicine, Hefei 230601, China  \nPPV  \nNPV  \nACP  \nROC NMP22 BTA FISH ImmunoCyt  \nPositive predict value Negative predict value Acid phosphatase  \nReceiver operating characteristic Nuclear matrix protein 22  \nBladder cancer antigen  \nFluorescence in situ hybridization  \nFluorescence immunohistochemistry  \nIntroduction  \nUroepithelial carcinoma (UC) is the most common type of bladder cancer, accounting for 90% of cases. It is a prevalent malignancy affecting the urinary tract. According to the American Cancer Society's Annual Review of Cancer Statistics 2022, bladder cancer ranks fourth in terms of  \nthe number of new cases among men and eighth in terms of the number of deaths among all cancers (Siegel et al. 2023) .  \nCystoscopy is considered the gold standard for diagnosing and monitoring bladder cancer. The diagnosis of bladder cancer relies on cystoscopy and histologic evaluation of tissue samples (Babjuk et","cbCaig7XjKvZI95I","https://ap.wps.com/l/cbCaig7XjKvZI95I","pdf",1078342,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n## Keywords\n# Introduction\n## Cystoscopy and limitations\n## Urine cytology and biomarkers\n## ELLBC concept and rationale\n# Methods\n## Patients and samples","[{\"question\":\"What is ELLBC and what marker does it use?\",\"answer\":\"ELLBC is an enzyme histochemical staining approach based on liquid-based cytology. It uses acid phosphatase as the marker to detect bladder cancer cells with abnormal elevation.\"},{\"question\":\"How was diagnostic performance of ELLBC evaluated?\",\"answer\":\"Diagnostic efficacy was calculated by comparing ELLBC and conventional cytology with histopathology, which served as the gold standard.\"},{\"question\":\"What were the main findings about ELLBC versus conventional cytology?\",\"answer\":\"ELLBC showed higher sensitivity and specificity than conventional cytology, with statistical significance reported (p \\u003c 0.05). Combining ELLBC with conventional cytology increased sensitivity, though diagnostic accuracy decreased.\"}]","Enzyme-labeled liquid-based cytology (ELLBC): a new noninvasive diagnostic method for bladder cancers | PDF",1790013566,18]